Alair News and Research

RSS

FDA Anesthesiology and Respiratory Therapy Devices Panel recommends approval for Asthmatx' Alair System

Asthmatx Inc., announced today that the Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee to the U.S. Food and Drug Administration (FDA) voted to recommend that the Alair® System, a device utilized in bronchial thermoplasty for the treatment of severe persistent asthma in patients 18 years and older, be found approvable with conditions.

29 Oct 2009

New asthma treatment bronchial thermoplasty improves patient quality of life

Chronic asthma sufferers may find new relief in a simple, minimally invasive outpatient procedure known as bronchial thermoplasty, which uses controlled radiofrequency-generated heat to treat the muscles of the airways, preventing them from constricting and narrowing.

18 May 2009

Asthmatx completes enrollment in study of bronchial thermoplasty

Asthmatx, Inc. has announced the successful completion of enrollment in its pivotal FDA approved IDE study, the Asthma Intervention Research 2 (AIR2) Trial of the Alair, Bronchial Thermoplasty System.

22 May 2007